2003
DOI: 10.1016/s0960-894x(02)00942-3
|View full text |Cite
|
Sign up to set email alerts
|

Thiophene-based vitronectin receptor antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…19 In addition, thiophene ring containing compounds exhibit different biological activities such as SGLT2 inhibitors, 20 antitumor, 21 antimicrobial, 22 DHODH inhibitors, 23 BACE1 inhibitors, 24 antioxidant, 25 c-Jun-N-terminal kinase inhibitor, 26 5-HT2A receptor antagonists, 27 anti-inflammatory 28 and vitronectin receptor antagonists. 29 In addition, 1,3-dioxolane ring containing compounds exhibit different biological activities such as antifungal, plant growth regulator, 30 and VLA-4 antagonists. 31 Our goal in this work was to incorporate these four independently biologically active moieties into one molecule to generate compounds with better biological activities.…”
mentioning
confidence: 99%
“…19 In addition, thiophene ring containing compounds exhibit different biological activities such as SGLT2 inhibitors, 20 antitumor, 21 antimicrobial, 22 DHODH inhibitors, 23 BACE1 inhibitors, 24 antioxidant, 25 c-Jun-N-terminal kinase inhibitor, 26 5-HT2A receptor antagonists, 27 anti-inflammatory 28 and vitronectin receptor antagonists. 29 In addition, 1,3-dioxolane ring containing compounds exhibit different biological activities such as antifungal, plant growth regulator, 30 and VLA-4 antagonists. 31 Our goal in this work was to incorporate these four independently biologically active moieties into one molecule to generate compounds with better biological activities.…”
mentioning
confidence: 99%